Skip to content

Monthly Archives: February 2012

Treatment Approved by FDA for StemCells Trial on Dry AMD

In a month, where the Pennsylvania Association for the Blind is creating awareness on Age-Related Macular Degeneration (AMD,) drug researcher StemCells Inc. (STEM) received authorization from the U.S. Food and Drug Administration (FDA) to start a clinical trial on the potential treatment for dry age-related macular degeneration.

Click Here for Full Article ยป